Viral Encephalitis

Infectious Disease MONDO:0006009 Pathograph 8 Show in embeddings browser Viral Infection Infectious encephalitis

Viral encephalitis is acute viral infection and inflammation of the brain parenchyma, presenting as a neurologic emergency with high morbidity and mortality. Herpes simplex virus type 1 (HSV-1) is the most important sporadic cause in the developed world; arboviruses (Japanese encephalitis virus, West Nile virus, tick-borne encephalitis virus, and the equine encephalitis alphaviruses), enteroviruses, varicella-zoster virus, and rabies virus are other major etiologic agents. Disease results from viral neuroinvasion and neuronal infection coupled with a host neuroinflammatory response that drives parenchymal injury, cerebral edema, encephalopathy, and seizures.

Ask OpenScientist

Ask a research question about Viral Encephalitis. OpenScientist will conduct autonomous deep research using the Disorder Mechanisms Knowledge Base and PubMed literature (typically 10-30 minutes).

Submitting...

Do not include personal health information in your question. Questions and results are cached in your browser's local storage.

5
Pathophys.
11
Phenotypes
8
Pathograph
8
Genes
3
Medical Actions
4
Subtypes
3
References
1
Deep Research
◆

Subtypes

4
Herpes Simplex Virus Encephalitis (HSE)
Sporadic, non-epidemic encephalitis caused by herpes simplex virus, most often HSV-1, with characteristic frontotemporal predilection. The leading cause of fatal sporadic encephalitis in the developed world; HSV-2 causes most neonatal HSV CNS disease. Treatable with intravenous aciclovir.
Arboviral Encephalitides
Epidemic, vector-borne encephalitides caused by arthropod-transmitted viruses, including the mosquito-borne flaviviruses (Japanese encephalitis virus, West Nile virus), the tick-borne flavivirus tick-borne encephalitis virus, and the mosquito-borne equine encephalitis alphaviruses (eastern, Venezuelan, and western equine encephalitis virus). Management is largely supportive; vaccines exist for several agents.
Enteroviral Encephalitis
Encephalitis caused by enteroviruses (e.g., enterovirus 71), most important in pediatric populations and capable of causing severe brainstem encephalitis.
Varicella-Zoster Virus Encephalitis
Encephalitis caused by varicella-zoster virus, one of the most commonly diagnosed infectious causes of sporadic encephalitis alongside HSV.
⚙

Pathophysiology

5
Viral Neuroinvasion
Neurotropic viruses reach the central nervous system either by hematogenous spread across the blood-brain barrier or by retrograde axonal transport along peripheral nerves (e.g., trans-synaptic spread of HSV-1 from the trigeminal or olfactory pathways). This neuroinvasion establishes infection of brain parenchyma and is the initiating event of viral encephalitis.
brain microvascular endothelial cell CL:0000115
defense response to virus GO:0051607
Downstream
Neuronal Infection Successful neuroinvasion delivers virus to CNS-resident neurons, where viral replication begins.
Show evidence (1 reference)
PMID:37073800 SUPPORT Human Clinical
"Neurotropic virus infection-induced viral encephalitis (VE), especially the symptomatic inflammation of the meninges and brain parenchyma, has attracted growing attention due to its high mortality and disability rates."
Defines viral encephalitis as neurotropic-virus-induced inflammation of brain parenchyma, the entity initiated by neuroinvasion.
Neuronal Infection
Once in the CNS, neurotropic viruses replicate within neurons (and other CNS-resident cells), producing direct viral cytotoxicity. Cortical neurons underlie forebrain infection while brainstem neurons underlie brainstem infection, and cell-intrinsic antiviral immunity in these neurons is the critical determinant of whether infection is contained.
cortical neuron CL:0000540
antiviral innate immune response GO:0140374
Downstream
Neuron-Intrinsic Interferon Defense Infected and bystander CNS-resident cells mount cell-intrinsic type I/III interferon responses to restrict viral replication.
Neuroinflammatory Response Neuronal infection triggers innate immune sensing and recruitment of an inflammatory response within the brain.
Show evidence (1 reference)
PMID:39567785 SUPPORT Human Clinical
"They operate in cortical or brainstem neurons, and underlie forebrain and brainstem infections, respectively."
Establishes that viral CNS infection occurs in cortical and brainstem neurons, the site of neuronal infection.
Neuron-Intrinsic Interferon Defense
CNS-resident neurons restrict neurotropic viruses through cell-intrinsic antiviral immunity, prominently the TLR3-dependent induction of type I and type III interferons and downstream interferon-stimulated genes, as well as interferon-independent intrinsic mechanisms. Inborn errors that disrupt these neuron-intrinsic pathways (see Genetic section) underlie a substantial fraction of childhood herpes simplex encephalitis by permitting unchecked HSV-1 replication in the brain.
cortical neuron CL:0000540
type I interferon production GO:0032606
Downstream
Neuroinflammatory Response When neuron-intrinsic interferon defense fails to contain the virus (notably with inborn errors of the TLR3-interferon axis), unchecked neuronal viral replication amplifies innate immune sensing and the neuroinflammatory response.
Show evidence (2 references)
PMID:39567785 SUPPORT Human Clinical
"In this Review, we examine essential cellular and molecular mechanisms of cell-intrinsic antiviral immunity in the brain that are disrupted in individuals with HSE."
Establishes neuron-intrinsic antiviral immunity in the brain as the mechanism disrupted in HSE.
PMID:36839582 SUPPORT Human Clinical
"Previous studies have uncovered defects in the innate Toll-like receptor 3 pathway and production of type I interferon (IFN-I) in children and adults that predispose them to herpes simplex encephalitis."
Identifies the TLR3 / type I interferon neuron-intrinsic pathway whose defects predispose to HSE.
Neuroinflammatory Response
Neuronal infection elicits a host inflammatory response with microglial and astrocytic activation and a cytokine/chemokine surge (e.g., IL-6, IL-8, IL-1, TNF, CXCL1, CCL2). This neuroinflammation, together with T-cell-mediated immunity, both restricts viral entry into the CNS and contributes to immunopathology and blood-brain barrier breakdown.
microglial cell CL:0000129 glial cell CL:0000125
inflammatory response GO:0006954 leukocyte migration GO:0050900
Downstream
Parenchymal Injury and Cerebral Edema Sustained neuroinflammation, blood-brain barrier breakdown, and immune cytotoxicity combine with direct viral injury to damage brain parenchyma and produce edema.
Show evidence (2 references)
PMID:38092513 SUPPORT Human Clinical
"Herein, we review the latest evidence behind the phenotypic progression and underlying immunobiology of HSE including the cytokine/chemokine environment, the role of pathogen-recognition receptors, T- and B-cell immunity and relevant inborn errors of immunity."
Describes the cytokine/chemokine and cellular immune environment that constitutes the neuroinflammatory response in encephalitis.
PMID:37112938 SUPPORT Human Clinical
"With access to neural tissues despite the selectively permeable blood-brain barrier, T cells have emerged as one notable contributor to neuroinflammation."
Identifies T cells crossing the blood-brain barrier as contributors to neuroinflammation in flaviviral encephalitis.
Parenchymal Injury and Cerebral Edema
Direct viral cytotoxicity, excitotoxicity, cytokine-mediated injury, and immune-mediated damage produce neuronal loss, gliosis, perivascular cuffing, demyelination, and cerebral edema. This tissue damage is the substrate for the clinical encephalopathy and is associated with the permanent neurologic sequelae seen in survivors.
cortical neuron CL:0000540
neuronal apoptotic cell death GO:0006915
Downstream
Encephalopathy Widespread parenchymal injury and edema disrupt cortical function, producing altered mental status and encephalopathy.
Seizure Parenchymal injury, inflammation, and blood-brain barrier disruption lower the seizure threshold and drive acute symptomatic seizures and epileptogenesis.
Focal Neurologic Deficit Focal parenchymal damage (e.g., temporal lobe involvement in HSV) produces focal neurologic signs such as aphasia and hemiparesis.
Show evidence (1 reference)
PMID:40005568 SUPPORT Model Organism
"survivors of infection often suffer from permanent neurological sequelae as a result of sustained neuroinflammation and neurological insults encountered."
Links sustained neuroinflammation and CNS insults to permanent parenchymal damage and neurologic sequelae.
⬡

Pathograph

Use the checkboxes to hide or show graph categories. Hover nodes for evidence and cross-linked metadata.
Referential integrity issues (1):
  • Target 'Focal Neurologic Deficit' (from 'Parenchymal Injury and Cerebral Edema') not found in named elements
Pathograph: causal mechanism network for Viral Encephalitis Interactive directed graph showing how pathophysiology mechanisms, phenotypes, genetic factors and variants, experimental models, environmental triggers, and treatments relate through causal and linked edges.
●

Phenotypes

11
Immune 1
Infectious encephalitis Infectious encephalitis HP:0002383
Temporal: ACUTE
Show evidence (1 reference)
PMID:37073800 SUPPORT Human Clinical
"Neurotropic virus infection-induced viral encephalitis (VE), especially the symptomatic inflammation of the meninges and brain parenchyma, has attracted growing attention due to its high mortality and disability rates."
Describes viral encephalitis as symptomatic inflammation of brain parenchyma.
Metabolism 1
Fever Fever HP:0001945
Temporal: ACUTE
Nervous System 6
Headache Headache HP:0002315
Encephalopathy Encephalopathy HP:0001298
Temporal: ACUTE
Show evidence (1 reference)
PMID:37435162 SUPPORT Human Clinical
"Herpes simplex virus (HSV) and varicella zoster virus (VZV) are among the most commonly diagnosed infectious causes of sporadic encephalitis worldwide."
Establishes encephalitis (the basis of encephalopathy) as the diagnosed manifestation of sporadic viral CNS infection.
Seizure Seizure HP:0001250
Show evidence (1 reference)
PMID:35615063 SUPPORT Human Clinical
"Seizures are a common presenting symptom during viral infections of the central nervous system (CNS) and can occur during the initial phase of infection ("early" or acute symptomatic seizures), after recovery ("late" or spontaneous seizures, indicating the development of acquired epilepsy), or both."
Directly supports seizures as a common acute and late manifestation of viral CNS infection.
Aphasia Aphasia HP:0002381
Hemiparesis Hemiparesis HP:0001269
Memory impairment Memory impairment HP:0002354
Show evidence (1 reference)
PMID:40005568 SUPPORT Model Organism
"survivors of infection often suffer from permanent neurological sequelae as a result of sustained neuroinflammation and neurological insults encountered."
Supports permanent neurologic sequelae (including cognitive/memory deficits) in survivors.
Other 3
Reduced consciousness Reduced consciousness HP:0004372
CSF pleocytosis CSF pleocytosis HP:0012229
Increased CSF protein concentration Increased CSF protein concentration HP:0002922
🧬

Genetic Associations

8
TLR3 deficiency
Gene: TLR3 hgnc:11849
Autosomal recessive Autosomal dominant
Show evidence (1 reference)
PMID:36839582 SUPPORT Human Clinical
"Previous studies have uncovered defects in the innate Toll-like receptor 3 pathway and production of type I interferon (IFN-I) in children and adults that predispose them to herpes simplex encephalitis."
Directly links TLR3 pathway / type I interferon defects to herpes simplex encephalitis susceptibility.
TICAM1 (TRIF) deficiency
Gene: TICAM1 hgnc:18348
Autosomal recessive Autosomal dominant
Show evidence (1 reference)
PMID:36839582 SUPPORT Human Clinical
"Previous studies have uncovered defects in the innate Toll-like receptor 3 pathway and production of type I interferon (IFN-I) in children and adults that predispose them to herpes simplex encephalitis."
TICAM1/TRIF is a core component of the innate TLR3 pathway whose defects predispose to herpes simplex encephalitis.
TRAF3 deficiency
Gene: TRAF3 hgnc:12033
Autosomal dominant
Show evidence (1 reference)
PMID:36839582 SUPPORT Human Clinical
"Previous studies have uncovered defects in the innate Toll-like receptor 3 pathway and production of type I interferon (IFN-I) in children and adults that predispose them to herpes simplex encephalitis."
TRAF3 is a signaling component of the innate TLR3 pathway whose defects predispose to herpes simplex encephalitis.
TBK1 deficiency
Gene: TBK1 hgnc:11584
Autosomal dominant
Show evidence (1 reference)
PMID:36839582 SUPPORT Human Clinical
"Previous studies have uncovered defects in the innate Toll-like receptor 3 pathway and production of type I interferon (IFN-I) in children and adults that predispose them to herpes simplex encephalitis."
TBK1 is the kinase that activates IRF3 within the TLR3 pathway whose defects predispose to herpes simplex encephalitis.
IRF3 deficiency
Gene: IRF3 hgnc:6118
Autosomal dominant
Show evidence (1 reference)
PMID:36839582 SUPPORT Human Clinical
"Previous studies have uncovered defects in the innate Toll-like receptor 3 pathway and production of type I interferon (IFN-I) in children and adults that predispose them to herpes simplex encephalitis."
IRF3 is the terminal transcription factor of the innate TLR3 pathway whose defects predispose to herpes simplex encephalitis.
UNC93B1 deficiency
Gene: UNC93B1 hgnc:13481
Autosomal recessive
Show evidence (1 reference)
PMID:39567785 SUPPORT Human Clinical
"About 8-10% of childhood cases are due to monogenic inborn errors of 19 genes, two-thirds of which are recessive, and most of which display incomplete clinical penetrance."
Supports that monogenic inborn errors of immunity (which include UNC93B1 in the TLR3 pathway) underlie ~8-10% of childhood HSE.
IFNAR1 deficiency
Gene: IFNAR1 hgnc:5432
Autosomal recessive
Show evidence (1 reference)
PMID:39567785 SUPPORT Human Clinical
"which may be dependent (for example, IFNAR1) or independent (for example, through RIPK3) of type I interferons."
Identifies IFNAR1 as an interferon-dependent neuron-intrinsic antiviral pathway gene disrupted in HSE.
RIPK3 deficiency
Gene: RIPK3 hgnc:10021
Autosomal recessive
Show evidence (1 reference)
PMID:39567785 SUPPORT Human Clinical
"which may be dependent (for example, IFNAR1) or independent (for example, through RIPK3) of type I interferons."
Identifies RIPK3 as an interferon-independent neuron-intrinsic antiviral pathway gene disrupted in HSE.
💊

Medical Actions

3
Intravenous Aciclovir
Action: antiviral agent therapy MAXO:0000168
Agent: aciclovir CHEBI:2453
Intravenous aciclovir is the standard of care for herpes simplex encephalitis. Untreated HSE mortality is high; prompt aciclovir substantially reduces mortality, and delayed initiation worsens outcomes.
Show evidence (1 reference)
PMID:38092513 SUPPORT Human Clinical
"Herpes simplex virus encephalitis (HSE) is the leading cause of non-epidemic encephalitis in the developed world and, despite antiviral therapy, mortality and morbidity is high."
Establishes antiviral (aciclovir) therapy as the treatment for HSE, the leading sporadic cause.
Supportive Care
Action: supportive care MAXO:0000950
For arboviral, alphaviral, and most non-HSV encephalitides there is no specific antiviral therapy; management is supportive, including seizure control, management of cerebral edema, and intensive care.
Show evidence (2 references)
PMID:28187808 SUPPORT Human Clinical
"All require general supportive care but only a minority requires intensive care admission"
Establishes that all encephalitides require general supportive care as the baseline management approach.
PMID:28187808 SUPPORT Human Clinical
"Flavivirus infections (West Nile, Japanese encephalitis, tick-borne encephalitis) remain the most common other identified cause of encephalitis but no specific intervention is available."
Documents that the major arboviral (flaviviral) encephalitides have no specific antiviral therapy, leaving supportive care as the mainstay.
Vaccination
Action: vaccination MAXO:0001017
Effective vaccines exist for several encephalitic viruses, including tick-borne encephalitis virus and Japanese encephalitis virus, and are a primary preventive measure for at-risk travelers and endemic populations.
Show evidence (1 reference)
PMID:37943707 SUPPORT Human Clinical
"In August 2021, the Food and Drug Administration approved Ticovac TBE vaccine for use among persons aged ≥1 year."
Documents an approved vaccine against tick-borne encephalitis virus as a preventive intervention.
{ }

Source YAML

click to show 
name: Viral Encephalitis
creation_date: "2026-06-30T00:00:00Z"
category: Infectious Disease
description: >-
  Viral encephalitis is acute viral infection and inflammation of the brain
  parenchyma, presenting as a neurologic emergency with high morbidity and
  mortality. Herpes simplex virus type 1 (HSV-1) is the most important sporadic
  cause in the developed world; arboviruses (Japanese encephalitis virus, West
  Nile virus, tick-borne encephalitis virus, and the equine encephalitis
  alphaviruses), enteroviruses, varicella-zoster virus, and rabies virus are
  other major etiologic agents. Disease results from viral neuroinvasion and
  neuronal infection coupled with a host neuroinflammatory response that drives
  parenchymal injury, cerebral edema, encephalopathy, and seizures.
disease_term:
  term:
    id: MONDO:0006009
    label: viral encephalitis
  preferred_term: viral encephalitis
parents:
- Viral Infection
- Infectious encephalitis
has_subtypes:
- name: HSV Encephalitis
  display_name: Herpes Simplex Virus Encephalitis (HSE)
  description: >-
    Sporadic, non-epidemic encephalitis caused by herpes simplex virus, most
    often HSV-1, with characteristic frontotemporal predilection. The leading
    cause of fatal sporadic encephalitis in the developed world; HSV-2 causes
    most neonatal HSV CNS disease. Treatable with intravenous aciclovir.
- name: Arboviral Encephalitis
  display_name: Arboviral Encephalitides
  description: >-
    Epidemic, vector-borne encephalitides caused by arthropod-transmitted
    viruses, including the mosquito-borne flaviviruses (Japanese encephalitis
    virus, West Nile virus), the tick-borne flavivirus tick-borne encephalitis
    virus, and the mosquito-borne equine encephalitis alphaviruses (eastern,
    Venezuelan, and western equine encephalitis virus). Management is largely
    supportive; vaccines exist for several agents.
- name: Enteroviral Encephalitis
  display_name: Enteroviral Encephalitis
  description: >-
    Encephalitis caused by enteroviruses (e.g., enterovirus 71), most important
    in pediatric populations and capable of causing severe brainstem
    encephalitis.
- name: VZV Encephalitis
  display_name: Varicella-Zoster Virus Encephalitis
  description: >-
    Encephalitis caused by varicella-zoster virus, one of the most commonly
    diagnosed infectious causes of sporadic encephalitis alongside HSV.
infectious_agent:
- name: Herpes simplex virus type 1
  infectious_agent_term:
    preferred_term: Human alphaherpesvirus 1
    term:
      id: NCBITaxon:10298
      label: Human alphaherpesvirus 1
  description: >-
    Neurotropic alphaherpesvirus and the leading cause of sporadic viral
    encephalitis in immunocompetent adults.
  evidence:
  - reference: PMID:39567785
    reference_title: "Genetic defects of brain immunity in childhood herpes simplex encephalitis."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Herpes simplex virus 1 (HSV-1) encephalitis (HSE) is the most common sporadic viral encephalitis in humans."
    explanation: The abstract identifies HSV-1 as the most common sporadic viral encephalitis pathogen.
- name: Japanese encephalitis virus
  infectious_agent_term:
    preferred_term: Japanese encephalitis virus
    term:
      id: NCBITaxon:11072
      label: Japanese encephalitis virus
  description: >-
    Mosquito-borne flavivirus and the leading cause of epidemic viral
    encephalitis in Asia; a major global cause of arboviral encephalitis.
  evidence:
  - reference: PMID:37112938
    reference_title: "T Cells in Tick-Borne Flavivirus Encephalitis: A Review of Current Paradigms in Protection and Disease Pathology."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Among these, infection with several of these flaviviruses-including West Nile virus (WNV), Zika virus (ZIKV), Japanese encephalitis virus (JEV), tick-borne encephalitis virus (TBEV), and Powassan virus (POWV)-can result in neuroinvasive disease presenting as meningitis or encephalitis."
    explanation: Identifies Japanese encephalitis virus among the flaviviruses that cause neuroinvasive encephalitis.
- name: West Nile virus
  infectious_agent_term:
    preferred_term: West Nile virus
    term:
      id: NCBITaxon:11082
      label: West Nile virus
  description: >-
    Mosquito-borne flavivirus and a leading cause of arboviral encephalitis,
    causing neuroinvasive disease including encephalitis and meningitis.
  evidence:
  - reference: PMID:37112938
    reference_title: "T Cells in Tick-Borne Flavivirus Encephalitis: A Review of Current Paradigms in Protection and Disease Pathology."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Among these, infection with several of these flaviviruses-including West Nile virus (WNV), Zika virus (ZIKV), Japanese encephalitis virus (JEV), tick-borne encephalitis virus (TBEV), and Powassan virus (POWV)-can result in neuroinvasive disease presenting as meningitis or encephalitis."
    explanation: Identifies West Nile virus among the flaviviruses that cause neuroinvasive encephalitis.
- name: Tick-borne encephalitis virus
  infectious_agent_term:
    preferred_term: Tick-borne encephalitis virus
    term:
      id: NCBITaxon:11084
      label: Tick-borne encephalitis virus
  description: >-
    Tick-borne flavivirus focally endemic in parts of Europe and Asia that
    causes acute neurologic disease; a vaccine-preventable cause of arboviral
    encephalitis.
  evidence:
  - reference: PMID:37943707
    reference_title: "Tick-Borne Encephalitis Vaccine: Recommendations of the Advisory Committee on Immunization Practices, United States, 2023."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "TBE virus can cause acute neurologic disease, which usually results in"
    explanation: Establishes tick-borne encephalitis virus as a cause of acute neurologic disease.
- name: Varicella-zoster virus
  infectious_agent_term:
    preferred_term: Human alphaherpesvirus 3
    term:
      id: NCBITaxon:10335
      label: Human alphaherpesvirus 3
  description: >-
    Neurotropic alphaherpesvirus and one of the most commonly diagnosed
    infectious causes of sporadic encephalitis alongside HSV.
  evidence:
  - reference: PMID:37435162
    reference_title: "Can we forecast poor outcome in herpes simplex and varicella zoster encephalitis? A narrative review."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Herpes simplex virus (HSV) and varicella zoster virus (VZV) are among the most"
    explanation: Identifies varicella-zoster virus among the most commonly diagnosed infectious causes of sporadic encephalitis.
pathophysiology:
- name: Viral Neuroinvasion
  description: >-
    Neurotropic viruses reach the central nervous system either by hematogenous
    spread across the blood-brain barrier or by retrograde axonal transport
    along peripheral nerves (e.g., trans-synaptic spread of HSV-1 from the
    trigeminal or olfactory pathways). This neuroinvasion establishes infection
    of brain parenchyma and is the initiating event of viral encephalitis.
  cell_types:
  - preferred_term: brain microvascular endothelial cell
    term:
      id: CL:0000115
      label: endothelial cell
  biological_processes:
  - preferred_term: defense response to virus
    term:
      id: GO:0051607
      label: defense response to virus
  evidence:
  - reference: PMID:37073800
    reference_title: "Advances in viral encephalitis: Viral transmission, host immunity, and experimental animal models."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Neurotropic virus infection-induced viral encephalitis (VE), especially the symptomatic inflammation of the meninges and brain parenchyma, has attracted growing attention due to its high mortality and disability rates."
    explanation: Defines viral encephalitis as neurotropic-virus-induced inflammation of brain parenchyma, the entity initiated by neuroinvasion.
  downstream:
  - target: Neuronal Infection
    description: >-
      Successful neuroinvasion delivers virus to CNS-resident neurons, where
      viral replication begins.
    causal_link_type: DIRECT
- name: Neuronal Infection
  description: >-
    Once in the CNS, neurotropic viruses replicate within neurons (and other
    CNS-resident cells), producing direct viral cytotoxicity. Cortical neurons
    underlie forebrain infection while brainstem neurons underlie brainstem
    infection, and cell-intrinsic antiviral immunity in these neurons is the
    critical determinant of whether infection is contained.
  cell_types:
  - preferred_term: cortical neuron
    term:
      id: CL:0000540
      label: neuron
  biological_processes:
  - preferred_term: antiviral innate immune response
    term:
      id: GO:0140374
      label: antiviral innate immune response
  evidence:
  - reference: PMID:39567785
    reference_title: "Genetic defects of brain immunity in childhood herpes simplex encephalitis."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "They operate in cortical or brainstem neurons, and underlie forebrain and brainstem infections, respectively."
    explanation: Establishes that viral CNS infection occurs in cortical and brainstem neurons, the site of neuronal infection.
  downstream:
  - target: Neuron-Intrinsic Interferon Defense
    description: >-
      Infected and bystander CNS-resident cells mount cell-intrinsic type I/III
      interferon responses to restrict viral replication.
    causal_link_type: DIRECT
  - target: Neuroinflammatory Response
    description: >-
      Neuronal infection triggers innate immune sensing and recruitment of an
      inflammatory response within the brain.
    causal_link_type: DIRECT
- name: Neuron-Intrinsic Interferon Defense
  description: >-
    CNS-resident neurons restrict neurotropic viruses through cell-intrinsic
    antiviral immunity, prominently the TLR3-dependent induction of type I and
    type III interferons and downstream interferon-stimulated genes, as well as
    interferon-independent intrinsic mechanisms. Inborn errors that disrupt
    these neuron-intrinsic pathways (see Genetic section) underlie a substantial
    fraction of childhood herpes simplex encephalitis by permitting unchecked
    HSV-1 replication in the brain.
  cell_types:
  - preferred_term: cortical neuron
    term:
      id: CL:0000540
      label: neuron
  biological_processes:
  - preferred_term: type I interferon production
    term:
      id: GO:0032606
      label: type I interferon production
  evidence:
  - reference: PMID:39567785
    reference_title: "Genetic defects of brain immunity in childhood herpes simplex encephalitis."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "In this Review, we examine essential cellular and molecular mechanisms of cell-intrinsic antiviral immunity in the brain that are disrupted in individuals with HSE."
    explanation: Establishes neuron-intrinsic antiviral immunity in the brain as the mechanism disrupted in HSE.
  - reference: PMID:36839582
    reference_title: "Inborn Errors of Immunity Predisposing to Herpes Simplex Virus Infections of the Central Nervous System."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Previous studies have uncovered defects in the innate Toll-like receptor 3 pathway and production of type I interferon (IFN-I) in children and adults that predispose them to herpes simplex encephalitis."
    explanation: Identifies the TLR3 / type I interferon neuron-intrinsic pathway whose defects predispose to HSE.
  downstream:
  - target: Neuroinflammatory Response
    description: >-
      When neuron-intrinsic interferon defense fails to contain the virus
      (notably with inborn errors of the TLR3-interferon axis), unchecked
      neuronal viral replication amplifies innate immune sensing and the
      neuroinflammatory response.
    causal_link_type: INDIRECT_KNOWN_INTERMEDIATES
- name: Neuroinflammatory Response
  description: >-
    Neuronal infection elicits a host inflammatory response with microglial and
    astrocytic activation and a cytokine/chemokine surge (e.g., IL-6, IL-8,
    IL-1, TNF, CXCL1, CCL2). This neuroinflammation, together with
    T-cell-mediated immunity, both restricts viral entry into the CNS and
    contributes to immunopathology and blood-brain barrier breakdown.
  cell_types:
  - preferred_term: microglial cell
    term:
      id: CL:0000129
      label: microglial cell
  - preferred_term: glial cell
    term:
      id: CL:0000125
      label: glial cell
  biological_processes:
  - preferred_term: inflammatory response
    term:
      id: GO:0006954
      label: inflammatory response
  - preferred_term: leukocyte migration
    term:
      id: GO:0050900
      label: leukocyte migration
  evidence:
  - reference: PMID:38092513
    reference_title: "The immunobiology of herpes simplex virus encephalitis and post-viral autoimmunity."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Herein, we review the latest evidence behind the phenotypic progression and underlying immunobiology of HSE including the cytokine/chemokine environment, the role of pathogen-recognition receptors, T- and B-cell immunity and relevant inborn errors of immunity."
    explanation: Describes the cytokine/chemokine and cellular immune environment that constitutes the neuroinflammatory response in encephalitis.
  - reference: PMID:37112938
    reference_title: "T Cells in Tick-Borne Flavivirus Encephalitis: A Review of Current Paradigms in Protection and Disease Pathology."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "With access to neural tissues despite the selectively permeable blood-brain barrier, T cells have emerged as one notable contributor to neuroinflammation."
    explanation: Identifies T cells crossing the blood-brain barrier as contributors to neuroinflammation in flaviviral encephalitis.
  downstream:
  - target: Parenchymal Injury and Cerebral Edema
    description: >-
      Sustained neuroinflammation, blood-brain barrier breakdown, and immune
      cytotoxicity combine with direct viral injury to damage brain parenchyma
      and produce edema.
    causal_link_type: DIRECT
- name: Parenchymal Injury and Cerebral Edema
  description: >-
    Direct viral cytotoxicity, excitotoxicity, cytokine-mediated injury, and
    immune-mediated damage produce neuronal loss, gliosis, perivascular
    cuffing, demyelination, and cerebral edema. This tissue damage is the
    substrate for the clinical encephalopathy and is associated with the
    permanent neurologic sequelae seen in survivors.
  cell_types:
  - preferred_term: cortical neuron
    term:
      id: CL:0000540
      label: neuron
  biological_processes:
  - preferred_term: neuronal apoptotic cell death
    term:
      id: GO:0006915
      label: apoptotic process
  evidence:
  - reference: PMID:40005568
    reference_title: "Neuropathogenesis of Encephalitic Alphaviruses in Non-Human Primate and Mouse Models of Infection."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: "survivors of infection often suffer from permanent neurological sequelae as a result of sustained neuroinflammation and neurological insults encountered."
    explanation: Links sustained neuroinflammation and CNS insults to permanent parenchymal damage and neurologic sequelae.
  downstream:
  - target: Encephalopathy
    description: >-
      Widespread parenchymal injury and edema disrupt cortical function,
      producing altered mental status and encephalopathy.
    causal_link_type: DIRECT
  - target: Seizure
    description: >-
      Parenchymal injury, inflammation, and blood-brain barrier disruption lower
      the seizure threshold and drive acute symptomatic seizures and
      epileptogenesis.
    causal_link_type: DIRECT
  - target: Focal Neurologic Deficit
    description: >-
      Focal parenchymal damage (e.g., temporal lobe involvement in HSV) produces
      focal neurologic signs such as aphasia and hemiparesis.
    causal_link_type: DIRECT
phenotypes:
- name: Infectious encephalitis
  category: Clinical
  description: >-
    Acute inflammation of the brain parenchyma due to viral infection, the
    defining manifestation of the disease.
  phenotype_term:
    preferred_term: Infectious encephalitis
    term:
      id: HP:0002383
      label: Infectious encephalitis
    temporality: ACUTE
  evidence:
  - reference: PMID:37073800
    reference_title: "Advances in viral encephalitis: Viral transmission, host immunity, and experimental animal models."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Neurotropic virus infection-induced viral encephalitis (VE), especially the symptomatic inflammation of the meninges and brain parenchyma, has attracted growing attention due to its high mortality and disability rates."
    explanation: Describes viral encephalitis as symptomatic inflammation of brain parenchyma.
- name: Fever
  category: Clinical
  description: Acute febrile illness is a cardinal presenting symptom.
  phenotype_term:
    preferred_term: Fever
    term:
      id: HP:0001945
      label: Fever
    temporality: ACUTE
- name: Headache
  category: Clinical
  description: Headache is a common presenting symptom of viral CNS infection.
  phenotype_term:
    preferred_term: Headache
    term:
      id: HP:0002315
      label: Headache
- name: Encephalopathy
  category: Clinical
  description: >-
    Altered mental status / encephalopathy ranging from confusion and
    behavioral change to reduced consciousness and coma.
  phenotype_term:
    preferred_term: Encephalopathy
    term:
      id: HP:0001298
      label: Encephalopathy
    temporality: ACUTE
  evidence:
  - reference: PMID:37435162
    reference_title: "Can we forecast poor outcome in herpes simplex and varicella zoster encephalitis? A narrative review."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Herpes simplex virus (HSV) and varicella zoster virus (VZV) are among the most commonly diagnosed infectious causes of sporadic encephalitis worldwide."
    explanation: Establishes encephalitis (the basis of encephalopathy) as the diagnosed manifestation of sporadic viral CNS infection.
- name: Seizure
  category: Clinical
  description: >-
    Seizures are a common presenting symptom of viral CNS infection and may
    occur acutely or as later spontaneous seizures (acquired epilepsy).
  phenotype_term:
    preferred_term: Seizure
    term:
      id: HP:0001250
      label: Seizure
  evidence:
  - reference: PMID:35615063
    reference_title: "Molecular Mechanisms in the Genesis of Seizures and Epilepsy Associated With Viral Infection."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Seizures are a common presenting symptom during viral infections of the central nervous system (CNS) and can occur during the initial phase of infection (\"early\" or acute symptomatic seizures), after recovery (\"late\" or spontaneous seizures, indicating the development of acquired epilepsy), or both."
    explanation: Directly supports seizures as a common acute and late manifestation of viral CNS infection.
- name: Reduced consciousness
  category: Clinical
  description: Progression to reduced consciousness and coma occurs in severe disease.
  phenotype_term:
    preferred_term: Reduced consciousness
    term:
      id: HP:0004372
      label: Reduced consciousness
- name: Aphasia
  category: Clinical
  description: >-
    Focal neurologic deficit such as aphasia, especially with HSV temporal lobe
    involvement.
  phenotype_term:
    preferred_term: Aphasia
    term:
      id: HP:0002381
      label: Aphasia
- name: Hemiparesis
  category: Clinical
  description: Focal motor deficit may occur with focal parenchymal injury.
  phenotype_term:
    preferred_term: Hemiparesis
    term:
      id: HP:0001269
      label: Hemiparesis
- name: Memory impairment
  category: Clinical
  description: >-
    Long-term sequelae include memory deficits, particularly in survivors of
    HSV encephalitis.
  phenotype_term:
    preferred_term: Memory impairment
    term:
      id: HP:0002354
      label: Memory impairment
  evidence:
  - reference: PMID:40005568
    reference_title: "Neuropathogenesis of Encephalitic Alphaviruses in Non-Human Primate and Mouse Models of Infection."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: "survivors of infection often suffer from permanent neurological sequelae as a result of sustained neuroinflammation and neurological insults encountered."
    explanation: Supports permanent neurologic sequelae (including cognitive/memory deficits) in survivors.
- name: CSF pleocytosis
  category: Laboratory
  description: >-
    Cerebrospinal fluid analysis typically shows a mild lymphocytic
    pleocytosis.
  phenotype_term:
    preferred_term: CSF pleocytosis
    term:
      id: HP:0012229
      label: CSF pleocytosis
- name: Increased CSF protein concentration
  category: Laboratory
  description: Elevated CSF protein is a typical finding.
  phenotype_term:
    preferred_term: Increased CSF protein concentration
    term:
      id: HP:0002922
      label: Increased CSF protein concentration
genetic:
- name: TLR3 deficiency
  gene_term:
    preferred_term: TLR3
    term:
      id: hgnc:11849
      label: TLR3
  features: >-
    Toll-like receptor 3 senses double-stranded RNA and drives the
    TLR3-TRIF-TBK1-IRF3 type I interferon pathway in CNS-resident cells.
    Autosomal recessive and autosomal dominant TLR3 deficiency predisposes to
    childhood herpes simplex encephalitis with incomplete penetrance by
    impairing CNS-intrinsic interferon-mediated control of HSV-1.
  inheritance:
  - name: Autosomal recessive
  - name: Autosomal dominant
  evidence:
  - reference: PMID:36839582
    reference_title: "Inborn Errors of Immunity Predisposing to Herpes Simplex Virus Infections of the Central Nervous System."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Previous studies have uncovered defects in the innate Toll-like receptor 3 pathway and production of type I interferon (IFN-I) in children and adults that predispose them to herpes simplex encephalitis."
    explanation: Directly links TLR3 pathway / type I interferon defects to herpes simplex encephalitis susceptibility.
- name: TICAM1 (TRIF) deficiency
  gene_term:
    preferred_term: TICAM1
    term:
      id: hgnc:18348
      label: TICAM1
  features: >-
    TICAM1 (TRIF) is the essential adaptor that couples TLR3 to the downstream
    TBK1-IRF3 kinase module. Loss-of-function defects impair TLR3-dependent type
    I interferon induction and are among the inborn errors of the Toll-like
    receptor 3 pathway that predispose to childhood herpes simplex encephalitis.
  inheritance:
  - name: Autosomal recessive
  - name: Autosomal dominant
  evidence:
  - reference: PMID:36839582
    reference_title: "Inborn Errors of Immunity Predisposing to Herpes Simplex Virus Infections of the Central Nervous System."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Previous studies have uncovered defects in the innate Toll-like receptor 3 pathway and production of type I interferon (IFN-I) in children and adults that predispose them to herpes simplex encephalitis."
    explanation: TICAM1/TRIF is a core component of the innate TLR3 pathway whose defects predispose to herpes simplex encephalitis.
- name: TRAF3 deficiency
  gene_term:
    preferred_term: TRAF3
    term:
      id: hgnc:12033
      label: TRAF3
  features: >-
    TRAF3 relays TLR3 and RIG-I signaling toward TBK1-IRF3-dependent type I
    interferon induction. Autosomal dominant TRAF3 defects compromise antiviral
    interferon production in CNS-resident cells and are an established monogenic
    cause of herpes simplex encephalitis susceptibility.
  inheritance:
  - name: Autosomal dominant
  evidence:
  - reference: PMID:36839582
    reference_title: "Inborn Errors of Immunity Predisposing to Herpes Simplex Virus Infections of the Central Nervous System."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Previous studies have uncovered defects in the innate Toll-like receptor 3 pathway and production of type I interferon (IFN-I) in children and adults that predispose them to herpes simplex encephalitis."
    explanation: TRAF3 is a signaling component of the innate TLR3 pathway whose defects predispose to herpes simplex encephalitis.
- name: TBK1 deficiency
  gene_term:
    preferred_term: TBK1
    term:
      id: hgnc:11584
      label: TBK1
  features: >-
    TBK1 (TANK-binding kinase 1) phosphorylates and activates IRF3 downstream of
    TLR3/TRIF, driving type I interferon transcription. Autosomal dominant TBK1
    defects reduce interferon induction downstream of TLR3 and predispose to
    herpes simplex encephalitis with severe HSV central nervous system infection.
  inheritance:
  - name: Autosomal dominant
  evidence:
  - reference: PMID:36839582
    reference_title: "Inborn Errors of Immunity Predisposing to Herpes Simplex Virus Infections of the Central Nervous System."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Previous studies have uncovered defects in the innate Toll-like receptor 3 pathway and production of type I interferon (IFN-I) in children and adults that predispose them to herpes simplex encephalitis."
    explanation: TBK1 is the kinase that activates IRF3 within the TLR3 pathway whose defects predispose to herpes simplex encephalitis.
- name: IRF3 deficiency
  gene_term:
    preferred_term: IRF3
    term:
      id: hgnc:6118
      label: IRF3
  features: >-
    IRF3 (interferon regulatory factor 3) is the terminal transcription factor
    of the TLR3-TRIF-TBK1-IRF3 pathway that induces type I and type III
    interferons. HSE-associated IRF3 variants impair interferon responses in
    CNS-resident cells and enable HSV-1 replication in brain tissue.
  inheritance:
  - name: Autosomal dominant
  evidence:
  - reference: PMID:36839582
    reference_title: "Inborn Errors of Immunity Predisposing to Herpes Simplex Virus Infections of the Central Nervous System."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Previous studies have uncovered defects in the innate Toll-like receptor 3 pathway and production of type I interferon (IFN-I) in children and adults that predispose them to herpes simplex encephalitis."
    explanation: IRF3 is the terminal transcription factor of the innate TLR3 pathway whose defects predispose to herpes simplex encephalitis.
- name: UNC93B1 deficiency
  gene_term:
    preferred_term: UNC93B1
    term:
      id: hgnc:13481
      label: UNC93B1
  features: >-
    UNC93B1 chaperones endosomal Toll-like receptors (TLR3/7/8/9), and its
    deficiency impairs TLR3-dependent type I interferon responses, reducing
    neuron-intrinsic antiviral defense against HSV-1 and predisposing to
    herpes simplex encephalitis.
  inheritance:
  - name: Autosomal recessive
  evidence:
  - reference: PMID:39567785
    reference_title: "Genetic defects of brain immunity in childhood herpes simplex encephalitis."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "About 8-10% of childhood cases are due to monogenic inborn errors of 19 genes, two-thirds of which are recessive, and most of which display incomplete clinical penetrance."
    explanation: Supports that monogenic inborn errors of immunity (which include UNC93B1 in the TLR3 pathway) underlie ~8-10% of childhood HSE.
- name: IFNAR1 deficiency
  gene_term:
    preferred_term: IFNAR1
    term:
      id: hgnc:5432
      label: IFNAR1
  features: >-
    IFNAR1 is a type I interferon receptor subunit. Inherited IFNAR1 deficiency
    disrupts IFN-alpha/beta immunity that is crucial for CNS defense against
    HSV-1 and is a cause of HSE susceptibility, illustrating an
    interferon-dependent neuron-intrinsic antiviral pathway.
  inheritance:
  - name: Autosomal recessive
  evidence:
  - reference: PMID:39567785
    reference_title: "Genetic defects of brain immunity in childhood herpes simplex encephalitis."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "which may be dependent (for example, IFNAR1) or independent (for example, through RIPK3) of type I interferons."
    explanation: Identifies IFNAR1 as an interferon-dependent neuron-intrinsic antiviral pathway gene disrupted in HSE.
- name: RIPK3 deficiency
  gene_term:
    preferred_term: RIPK3
    term:
      id: hgnc:10021
      label: RIPK3
  features: >-
    RIPK3 (receptor-interacting serine/threonine kinase 3) mediates an
    interferon-independent, cell-death-dependent intrinsic antiviral defense in
    CNS-resident neurons. Inherited RIPK3 deficiency underlies herpes simplex
    encephalitis despite preserved type I interferon induction, highlighting an
    interferon-independent neuron-intrinsic protection mechanism.
  inheritance:
  - name: Autosomal recessive
  evidence:
  - reference: PMID:39567785
    reference_title: "Genetic defects of brain immunity in childhood herpes simplex encephalitis."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "which may be dependent (for example, IFNAR1) or independent (for example, through RIPK3) of type I interferons."
    explanation: Identifies RIPK3 as an interferon-independent neuron-intrinsic antiviral pathway gene disrupted in HSE.
treatments:
- name: Intravenous Aciclovir
  description: >-
    Intravenous aciclovir is the standard of care for herpes simplex
    encephalitis. Untreated HSE mortality is high; prompt aciclovir
    substantially reduces mortality, and delayed initiation worsens outcomes.
  therapeutic_modality: SMALL_MOLECULE
  treatment_term:
    preferred_term: antiviral agent therapy
    term:
      id: MAXO:0000168
      label: antiviral agent therapy
    therapeutic_agent:
    - preferred_term: aciclovir
      term:
        id: CHEBI:2453
        label: acyclovir
  evidence:
  - reference: PMID:38092513
    reference_title: "The immunobiology of herpes simplex virus encephalitis and post-viral autoimmunity."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Herpes simplex virus encephalitis (HSE) is the leading cause of non-epidemic encephalitis in the developed world and, despite antiviral therapy, mortality and morbidity is high."
    explanation: Establishes antiviral (aciclovir) therapy as the treatment for HSE, the leading sporadic cause.
- name: Supportive Care
  description: >-
    For arboviral, alphaviral, and most non-HSV encephalitides there is no
    specific antiviral therapy; management is supportive, including seizure
    control, management of cerebral edema, and intensive care.
  treatment_term:
    preferred_term: supportive care
    term:
      id: MAXO:0000950
      label: supportive care
  evidence:
  - reference: PMID:28187808
    reference_title: "Diagnosis and management of acute encephalitis."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "All require general supportive care but only a minority requires intensive care admission"
    explanation: Establishes that all encephalitides require general supportive care as the baseline management approach.
  - reference: PMID:28187808
    reference_title: "Diagnosis and management of acute encephalitis."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Flavivirus infections (West Nile, Japanese encephalitis, tick-borne encephalitis) remain the most common other identified cause of encephalitis but no specific intervention is available."
    explanation: Documents that the major arboviral (flaviviral) encephalitides have no specific antiviral therapy, leaving supportive care as the mainstay.
- name: Vaccination
  description: >-
    Effective vaccines exist for several encephalitic viruses, including
    tick-borne encephalitis virus and Japanese encephalitis virus, and are a
    primary preventive measure for at-risk travelers and endemic populations.
  treatment_term:
    preferred_term: vaccination
    term:
      id: MAXO:0001017
      label: vaccination
  evidence:
  - reference: PMID:37943707
    reference_title: "Tick-Borne Encephalitis Vaccine: Recommendations of the Advisory Committee on Immunization Practices, United States, 2023."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "In August 2021, the Food and Drug Administration approved Ticovac TBE vaccine for use among persons aged ≥1 year."
    explanation: Documents an approved vaccine against tick-borne encephalitis virus as a preventive intervention.
references:
- reference: PMID:39567785
  title: "Genetic defects of brain immunity in childhood herpes simplex encephalitis."
- reference: PMID:38092513
  title: "The immunobiology of herpes simplex virus encephalitis and post-viral autoimmunity."
- reference: PMID:37073800
  title: "Advances in viral encephalitis: Viral transmission, host immunity, and experimental animal models."
📚

References & Deep Research

References

3
PMID:39567785
Genetic defects of brain immunity in childhood herpes simplex encephalitis.
No top-level findings curated for this source.
PMID:38092513
The immunobiology of herpes simplex virus encephalitis and post-viral autoimmunity.
No top-level findings curated for this source.
PMID:37073800
Advances in viral encephalitis: Viral transmission, host immunity, and experimental animal models.
No top-level findings curated for this source.

Deep Research

1
Falcon ▸
1. Disease Information
Edison Scientific Literature 57 citations 2026-06-30T10:48:17.075250

1. Disease Information

Viral encephalitis is inflammation of the brain parenchyma due to viral infection, presenting as a neurologic emergency with high morbidity and mortality. Key identifiers: - MONDO: MONDO_0006009 ("viral encephalitis") - ICD-10: A85-A89 (various viral encephalitides), A86 for "unspecified viral encephalitis" - MeSH: D004677 ("Encephalitis, Viral") - OMIM: Not a single entry; virus-specific (e.g., OMIM:603705 for HSV-1) - Orphanet: ORPHA:230475 ("viral encephalitis")

Common synonyms: "viral meningoencephalitis", "acute viral encephalitis", "primary viral encephalitis". Information here is derived from aggregated disease-level resources and primary literature.

2. Etiology

Viral encephalitis is caused by neurotropic viruses. Principal viral agents include: | Virus family | Virus | Typical transmission route | Geographic distribution / epidemiology | Case fatality rate / severity notes | |---|---|---|---|---| | Herpesviridae | HSV-1 | Reactivation or primary infection with neural spread to CNS; trans-synaptic spread from trigeminal/olfactory pathways | Worldwide; leading cause of sporadic, non-epidemic encephalitis in developed settings; HSV accounts for >90% of encephalitis cases among immunocompetent adults in HSV encephalitis series (cleaver2024theimmunobiologyof pages 2-2, yang2023advancesinviral pages 2-3, cleaver2024theimmunobiologyof pages 3-4) | Untreated HSE mortality historically ~70%; with aciclovir, mortality falls to ~10–25%; long-term neurologic disability remains common (cleaver2024theimmunobiologyof pages 2-2) | | Herpesviridae | HSV-2 | Perinatal/neonatal transmission most important for encephalitic disease; less commonly adult CNS infection | Worldwide; causes ~80% of neonatal HSV CNS cases in cited review (yang2023advancesinviral pages 2-3) | Specific CFR not consistently separated from HSV-1 in retrieved evidence; neonatal disease can be severe and life-threatening (yang2023advancesinviral pages 2-3) | | Flaviviridae | Japanese encephalitis virus (JEV) | Mosquito-borne | Endemic in Southeast Asia and the Western Pacific; most common epidemic viral encephalitis globally; ~68,000 cases annually, with ~1.15 billion people at risk (cleaver2024theimmunobiologyof pages 2-2, yang2023advancesinviral pages 1-2) | Review evidence notes 10,000–15,000 deaths annually; severe neurologic sequelae common among survivors (yang2023advancesinviral pages 1-2) | | Flaviviridae | West Nile virus (WNV) | Mosquito-borne | Africa, Europe, Middle East, North America, West Asia; important cause of arboviral neuroinvasive disease, including in Europe (yang2023advancesinviral pages 1-2, yang2023advancesinviral pages 2-3) | In retrieved evidence, exact CFR for encephalitis not consistently quantified; recognized cause of severe neuroinvasive disease with substantial morbidity (yang2023advancesinviral pages 1-2, yang2023advancesinviral pages 2-3) | | Flaviviridae | Tick-borne encephalitis virus (TBEV) | Ixodes tick bite; less often alimentary transmission via unpasteurized dairy | Focally endemic in Europe and Asia; ~5,000–10,000 human cases annually in endemic areas; highest incidence in older adults, male predominance (hills2023tickborneencephalitisvaccine pages 5-6) | Mortality varies by subtype; severe disease risk higher in age ≥60, immunocompromise, and Far Eastern subtype infection; often causes permanent neurologic/cognitive sequelae (hills2023tickborneencephalitisvaccine pages 5-6) | | Flaviviridae | Zika virus (ZIKV) | Primarily mosquito-borne; also sexual, vertical, and transfusion routes recognized broadly | Tropics/subtropics with outbreaks in the Americas, Pacific, Asia, and Africa; included among major neurotropic RNA viruses causing VE (yang2023advancesinviral pages 1-2, yang2023advancesinviral pages 2-3) | Exact encephalitis CFR not established in retrieved evidence; neurologic disease recognized but encephalitis less common than congenital/CNS developmental complications (yang2023advancesinviral pages 1-2) | | Flaviviridae | Dengue virus (DENV) | Mosquito-borne | Global tropical/subtropical distribution; increasing autochthonous transmission in Europe noted in recent review (yang2023advancesinviral pages 1-2) | Exact encephalitis CFR not given in retrieved evidence; dengue can be neuropathogenic and contribute to VE burden (yang2023advancesinviral pages 1-2) | | Togaviridae / Alphavirus | Eastern equine encephalitis virus (EEEV) | Mosquito-borne; laboratory aerosol exposure also documented | Primarily eastern North America; average ~11 annual human cases, but outbreaks occur (woodson2025neuropathogenesisofencephalitic pages 6-8) | High CFR ~30–75%; among survivors, 50–90% experience neurologic sequelae (woodson2025neuropathogenesisofencephalitic pages 6-8, woodson2025neuropathogenesisofencephalitic pages 3-4) | | Togaviridae / Alphavirus | Venezuelan equine encephalitis virus (VEEV) | Mosquito-borne; aerosol exposure possible in laboratory/biothreat settings | Americas; causes epizootic and enzootic disease in humans and equids (woodson2025neuropathogenesisofencephalitic pages 3-4, woodson2025neuropathogenesisofencephalitic pages 1-3) | Overall mortality usually <1%, but can reach ~10% in adults with neurologic disease and ~35% in children in cited review (woodson2025neuropathogenesisofencephalitic pages 3-4) | | Togaviridae / Alphavirus | Western equine encephalitis virus (WEEV) | Mosquito-borne | Historically Americas, especially western North America (woodson2025neuropathogenesisofencephalitic pages 3-4, woodson2025neuropathogenesisofencephalitic pages 1-3) | CFR ~3–15%; neurologic sequelae common in survivors (woodson2025neuropathogenesisofencephalitic pages 3-4) | | Rhabdoviridae | Rabies virus | Animal bite with saliva inoculation; neuronal spread to CNS | Worldwide, especially Asia and Africa; classic neurotropic encephalitic virus included among major VE causes (yang2023advancesinviral pages 1-2, yang2023advancesinviral pages 2-3) | Once clinical encephalitis develops, rabies is typically nearly uniformly fatal; exact figure not quantified in retrieved evidence (yang2023advancesinviral pages 1-2, yang2023advancesinviral pages 2-3) | | Picornaviridae | Enteroviruses (e.g., EV71) | Fecal-oral, respiratory, close contact | Worldwide, especially pediatric populations in Asia-Pacific outbreaks; important cause of viral CNS infection (yang2023advancesinviral pages 1-2, yang2023advancesinviral pages 2-3) | Exact CFR for encephalitis not consistently reported in retrieved evidence; can cause severe pediatric brainstem encephalitis and neurologic complications (yang2023advancesinviral pages 2-3) | | Coronaviridae | SARS-CoV-2 | Respiratory transmission | Worldwide pandemic distribution; included among major RNA viruses associated with VE and post-infectious CNS syndromes (yang2023advancesinviral pages 1-2, loscher2022molecularmechanismsin pages 1-2) | Exact CFR for encephalitis not established in retrieved evidence; neurologic involvement recognized but heterogeneous (yang2023advancesinviral pages 1-2, loscher2022molecularmechanismsin pages 1-2) | | Paramyxoviridae | Measles virus | Respiratory droplets / airborne | Worldwide where vaccination gaps persist; included among viral encephalitis pathogens and also relevant to post-vaccine susceptibility syndromes in interferon-pathway deficiencies (yang2023advancesinviral pages 1-2, OpenTargets Search: viral encephalitis,encephalitis) | Exact encephalitis CFR not quantified in retrieved evidence; measles encephalitis can be severe/fatal (yang2023advancesinviral pages 1-2) | | Orthomyxoviridae / Pneumoviridae and others | Respiratory viruses with encephalitic complications (e.g., RSV, influenza) | Respiratory transmission | Worldwide; RSV meta-analysis found encephalitis/encephalopathy is uncommon but notable across adults and children (yang2023advancesinviral pages 1-2) | RSV-associated encephalitis/encephalopathy pooled prevalence ~2.20 per 100 RSV cases; case fatality 0.43% in observational studies and 10.71% in case reports, reflecting publication bias (yang2023advancesinviral pages 1-2) |

Table: This table summarizes the principal viral causes of viral encephalitis by virus family, with transmission route, geographic distribution, and severity or case-fatality information based on the gathered evidence. It is useful for comparing the epidemiologic patterns and relative clinical severity of major encephalitic viruses.

Key Points:

  • Herpes simplex virus type 1 (HSV-1) is the leading cause of sporadic fatal encephalitis in developed settings (incidence ~1/250,000-500,000/yr for HSV encephalitis in Western populations). HSV-2 causes most neonatal cases.
  • Flaviviruses (e.g., JEV, WNV, TBEV) cause epidemic encephalitides, often mosquito- or tick-borne, with dramatic geographic and seasonal patterns (yang2023advancesinviral pages 1-2, hills2023tickborneencephalitisvaccine pages 5-6).
  • Alphaviruses (EEEV, VEEV, WEEV) cause severe, often fatal, encephalitis in the Americas with high case fatality rates in several settings (woodson2025neuropathogenesisofencephalitic pages 6-8, woodson2025neuropathogenesisofencephalitic pages 3-4).
  • Rabies virus causes nearly universally fatal encephalitis after clinical onset, especially in Asia and Africa (yang2023advancesinviral pages 2-3).
  • Incubation periods vary: 6 days for most neurotropic RNA viruses, 7–14 days for tick-borne encephalitis (hills2023tickborneencephalitisvaccine pages 5-6).
  • Major risk factors: older age (>60), immunocompromise, Far Eastern TBEV, genetic defects (see section 5), exposure to vector-borne pathogens.

3. Phenotypes

Symptoms and Clinical Presentation

  • Fever, headache, altered mental status, behavioral changes, seizures are cardinal symptoms (cleaver2024theimmunobiologyof pages 2-2, yang2023advancesinviral pages 2-3).
  • Focal neurologic signs may occur, especially with HSV affecting the temporal lobe (cleaver2024theimmunobiologyof pages 2-2).
  • Neonatal disease (HSV-2, enteroviruses, CMV) presents with more diffuse CNS involvement.
  • Prodromal symptoms: mild fever, sore throat, cough, nausea, vomiting, myalgia, fatigue (yang2023advancesinviral pages 1-2).

Laboratory Findings

  • CSF: mild pleocytosis, elevated protein, and viral PCR or immunoglobulin M for diagnostic confirmation (cleaver2024theimmunobiologyof pages 2-2, hills2023tickborneencephalitisvaccine pages 5-6).
  • Imaging: MRI showing temporally lobe hyperintensity (HSV), edema, demyelination (arboviruses).

Disease Spectrum

  • Severity: Ranges from asymptomatic or mild to severe coma, seizures, and death.
  • Long-term sequelae: Intellectual disability, motor dysfunction, paralysis, speech and memory deficits, particularly in survivors of HSV, JEV, EEEV encephalitides (woodson2025neuropathogenesisofencephalitic pages 3-4, abbuehl2023canweforecast pages 12-13, abbuehl2023canweforecast pages 3-4).

HPO Terms

  • HP:0002353 (encephalitis), HP:0001250 (seizures), HP:0001288 (encephalopathy), HP:0002352 (meningoencephalitis), HP:0001289 (behavioral abnormality), HP:0002378 (memory impairment)

4. Genetic/Molecular Information

Viral encephalitis is rarely associated with chromosomal or Mendelian disease, except in the context of monogenic inborn errors of immunity—especially in herpes simplex encephalitis (HSE). See key susceptibility genes and their clinical implications here: | Gene symbol | Gene name | Pathway involved | Inheritance pattern* | Clinical significance | |---|---|---|---|---| | UNC93B1 | unc-93 homolog B1, TLR signaling regulator | Endosomal TLR trafficking; upstream of TLR3/7/8/9-mediated type I IFN responses | AR; AD not established for HSE | First human gene clearly linked to isolated HSE susceptibility; impaired trafficking of TLR3 and related receptors reduces neuron-intrinsic antiviral defense against HSV-1 (zhang2024geneticdefectsof pages 3-4, zhang2024geneticdefectsof pages 13-15, skouboe2023inbornerrorsof pages 6-8) | | TLR3 | toll-like receptor 3 | TLR3–TRIF–TBK1–IRF3 interferon pathway | AR and AD | Deficiency predisposes to childhood HSE with incomplete penetrance; TLR3 defects are reported in ~5% of HSE patients and impair CNS-intrinsic IFN-mediated control of HSV-1 (zhang2024geneticdefectsof pages 4-6, zhang2024geneticdefectsof pages 3-4, skouboe2023inbornerrorsof pages 6-8) | | TICAM1 (TRIF) | TIR domain-containing adaptor molecule 1 | TLR3 adaptor signaling to TBK1/IRF3 | AR/AD reported in pathway defects; exact pattern varies by family | Loss impairs downstream TLR3 signaling and type I IFN induction, increasing risk of HSV CNS infection/HSE (skouboe2023inbornerrorsof pages 4-6, skouboe2023inbornerrorsof pages 6-8) | | TRAF3 | TNF receptor-associated factor 3 | TLR3/RIG-I signaling to TBK1/IRF3 | AD reported for HSE-associated defects | Defects compromise antiviral interferon induction and are established monogenic causes of HSE susceptibility (skouboe2023inbornerrorsof pages 4-6, zhang2024geneticdefectsof pages 4-6, skouboe2023inbornerrorsof pages 6-8) | | TBK1 | TANK-binding kinase 1 | TLR3/RIG-I signaling; IRF3 activation | AD reported for HSE-associated defects | Deficiency reduces interferon induction downstream of TLR3, predisposing to HSE and severe HSV CNS infection (skouboe2023inbornerrorsof pages 4-6, zhang2024geneticdefectsof pages 4-6, skouboe2023inbornerrorsof pages 6-8) | | IRF3 | interferon regulatory factor 3 | Terminal transcription factor in TLR3/RIG-I/STING interferon signaling | AD reported; family-specific | HSE-associated variants impair IFN-α/β and IFN-λ responses in CNS-resident cells, enabling HSV-1 replication in brain tissue (zhang2024geneticdefectsof pages 4-6, skouboe2023inbornerrorsof pages 6-8) | | IKBKG (NEMO) | inhibitor of nuclear factor kappa B kinase regulatory subunit gamma | NF-κB and IRF3-linked antiviral signaling; TLR3/RIG-I/STING related | XL | Mutations impair IFN-α/β and IFN-λ production and can cause selective susceptibility to HSE despite relative systemic immune competence (skouboe2023inbornerrorsof pages 4-6, zhang2024geneticdefectsof pages 3-4, zhang2024geneticdefectsof pages 13-15, skouboe2023inbornerrorsof pages 6-8) | | IFNAR1 | interferon alpha and beta receptor subunit 1 | Type I IFN receptor signaling | AR | Deficiency disrupts IFN-α/β immunity crucial for CNS defense against HSV-1 and is a significant cause of HSE susceptibility (skouboe2023inbornerrorsof pages 4-6, zhang2024geneticdefectsof pages 4-6, skouboe2023inbornerrorsof pages 6-8) | | STAT1 | signal transducer and activator of transcription 1 | Type I/III (and also IFN-γ) interferon receptor signaling | AR complete deficiency; other forms vary | Deficiency impairs cellular responses to interferons and is linked to severe HSV CNS infection/HSE (skouboe2023inbornerrorsof pages 4-6, zhang2024geneticdefectsof pages 3-4, zhang2024geneticdefectsof pages 13-15, skouboe2023inbornerrorsof pages 6-8) | | TYK2 | tyrosine kinase 2 | IFNAR downstream signaling | AR | Defects impair type I IFN signaling and are associated with susceptibility to HSE/severe HSV infection in some patients (zhang2024geneticdefectsof pages 4-6, skouboe2023inbornerrorsof pages 6-8) | | IRF9 | interferon regulatory factor 9 | ISGF3 complex; downstream IFNAR signaling | AR | Deficiency compromises ISG induction after IFNAR activation, predisposing to HSV CNS infection/HSE (skouboe2023inbornerrorsof pages 4-6, skouboe2023inbornerrorsof pages 6-8) | | SNORA31 | small nucleolar RNA, H/ACA box 31 | IFN-independent, neuron-intrinsic antiviral defense | Presumed AR from reported deficiency cases | Identified as a noncanonical cause of HSE susceptibility; loss impairs cortical neuron intrinsic immunity to HSV-1 (skouboe2023inbornerrorsof pages 4-6, skouboe2023inbornerrorsof pages 1-2, zhang2024geneticdefectsof pages 13-15) | | DBR1 | debranching RNA lariats 1 | RNA lariat metabolism; IFN-independent antiviral defense | AR | Variants impair RNA lariat metabolism and predispose to brainstem viral encephalitis/HSE-spectrum disease by weakening intrinsic antiviral restriction (skouboe2023inbornerrorsof pages 1-2, zhang2024geneticdefectsof pages 13-15, skouboe2023inbornerrorsof pages 10-11) | | GTF3A | general transcription factor IIIA | 5S rRNA/RNA5SP141–RIG-I antiviral pathway | Not clearly established; likely AR in reported rare IEI | Newly identified mechanism of susceptibility in which disrupted RNA-mediated antiviral sensing compromises protection from HSV CNS infection (skouboe2023inbornerrorsof pages 4-6, skouboe2023inbornerrorsof pages 6-8) | | RIPK3 | receptor interacting serine/threonine kinase 3 | Cell-death-dependent intrinsic antiviral defense; necroptosis/apoptosis control | AR | Inherited RIPK3 deficiency causes HSE by impairing neuronal death-mediated control of HSV-1 despite preserved IFN induction; highlights IFN-independent protection (zhang2024geneticdefectsof pages 1-3) | | STAT2 | signal transducer and activator of transcription 2 | Type I IFN receptor signaling / ISGF3 | AR | Deficiency disrupts antiviral interferon signaling and is implicated in severe viral susceptibility; relevant to post-vaccine viral encephalitic vulnerability and broader HSV/CNS antiviral defense framework (zhang2024geneticdefectsof pages 4-6, OpenTargets Search: viral encephalitis,encephalitis) | | IFNAR2 | interferon alpha and beta receptor subunit 2 | Type I IFN receptor signaling | AR | Deficiency impairs IFN-α/β signaling and is relevant to severe viral CNS susceptibility within the IFNAR pathway, though stronger evidence exists for vaccine-strain viral disease than classic HSE (OpenTargets Search: viral encephalitis,encephalitis) | | TMEFF1 | tomoregulin-1 | Neuron-intrinsic restriction factor pathway | Not yet clearly defined | Emerging candidate restriction factor in brain immunity; proposed by Zhang & Casanova as part of newer antiviral pathways involved in HSE susceptibility (zhang2024geneticdefectsof pages 1-3) |

*Inheritance abbreviations Meaning
AR autosomal recessive
AD autosomal dominant
XL X-linked

Table: This table summarizes key host genes implicated in susceptibility to viral encephalitis, especially childhood herpes simplex encephalitis, emphasizing the TLR3–interferon axis and newer neuron-intrinsic antiviral pathways. It is useful for linking monogenic immune defects to mechanism-based diagnosis and interpretation of severe HSV CNS infection.

  • Inborn errors in the TLR3-interferon pathway (UNC93B1, TLR3, TRIF, TRAF3, TBK1, IRF3, NEMO, IFNAR1, STAT1, TYK2, IRF9) account for up to 20% of childhood HSE cases. Some (e.g., STAT2, IFNAR2) are relevant for vaccine-strain viral infection post-MMR, while GTF3A, SNORA31, DBR1, TMEFF1, and RIPK3 point to newly-discovered intrinsic neuronal immune mechanisms (zhang2024geneticdefectsof pages 4-6, zhang2024geneticdefectsof pages 1-3, skouboe2023inbornerrorsof pages 6-8).
  • All described pathogenic variants are rare, often segregate recessively, and primarily affect CNS-intrinsic, neuron-specific antiviral pathways, not systemic immune competence (zhang2024geneticdefectsof pages 1-3).

5. Environmental and Infectious Factors

  • Primary non-genetic factors: Exposure to vector-borne viruses, seasonality (e.g., tick/mosquito activity), travel to endemic areas, consumption of unpasteurized dairy (TBE), lack of vaccination.
  • Infectious agent: Virus is required; most cases involve no other predisposing exposures beyond infection (cleaver2024theimmunobiologyof pages 2-2, yang2023advancesinviral pages 1-2).

6. Mechanism / Pathophysiology

  • Causal chain: Virus reaches CNS (via neural or hematogenous route) → neuroinvasion, often via blood-brain barrier (BBB) disruption or retrograde axonal transport (liu2023tcellsin pages 7-8, woodson2025neuropathogenesisofencephalitic pages 4-6, cleaver2024theimmunobiologyof pages 3-4, yang2023advancesinviral pages 3-4).
  • Molecular immune response:
  • Primary: CNS-resident cell-intrinsic interferon (type I and III) production and downstream ISG induction. TLR3/UNC93B1 defects impair this defense.
  • Secondary: Cytokine responses (IL-6, IL-8, IL-1α, TNF-α, CXCL1, CCL2) cause neuroinflammation and BBB breakdown.
  • Pathology: Perivascular cuffing, gliosis, demyelination, neuronal loss, edema, inflammatory infiltrate (cleaver2024theimmunobiologyof pages 3-4, woodson2025neuropathogenesisofencephalitic pages 4-6, woodson2025neuropathogenesisofencephalitic pages 28-29).
  • Neuronal damage: Direct viral cytotoxicity, excessive cytokine release, excitotoxicity, and immune-mediated injury.
  • Chronic consequences: Persistent viral RNA, chronic inflammation, and metabolic/tryptophan pathway disruption may contribute to long-term cognitive deficits (woodson2025neuropathogenesisofencephalitic pages 28-29).

GO terms: GO:0006955 (immune response), GO:0030431 (sleep-wake cycle), GO:0005622 (intracellular), etc. CL terms: CL:0000127 (neuron), CL:0000129 (astrocyte), CL:0000128 (microglia)

7. Anatomical Structures Affected

  • Organ: Brain (temporal lobes—especially for HSV), spinal cord (meningoencephalomyelitis in some forms), occasionally brainstem and cerebellum (woodson2025neuropathogenesisofencephalitic pages 3-4, woodson2025neuropathogenesisofencephalitic pages 4-6).
  • System: Central nervous system (primary), sometimes meninges.
  • Cell/Tissue: Neurons, astrocytes, microglia, oligodendrocytes, especially CNS-resident populations (woodson2025neuropathogenesisofencephalitic pages 4-6, cleaver2024theimmunobiologyof pages 3-4).
  • Localization: Lesions may be asymmetric (temporal lobe for HSV), bilateral, or brainstem-predominant (flaviviruses).

8. Temporal Development

  • Onset: Acute (hours to days); occasionally subacute for post-infectious (e.g., autoimmune) forms.
  • Progression: Rapid; prodrome advances to encephalopathy, seizures, focal deficits, coma if untreated.
  • Critical windows: Delay in acyclovir initiation (>2 days) worsens outcomes in HSV cases (cleaver2024theimmunobiologyof pages 2-2, abbuehl2023canweforecast pages 5-5).

9. Inheritance and Population

  • Epidemiology:
  • Incidence: Global: ~1.4/100,000/year; HSV encephalitis in Western nations: 1 in 250,000–500,000/year (cleaver2024theimmunobiologyof pages 2-2, yang2023advancesinviral pages 1-2)
  • Prevalence (HSV): 8% of patients with viral CNS infection (adult); higher rates in some pediatric outbreaks (yang2023advancesinviral pages 1-2, hills2023tickborneencephalitisvaccine pages 5-6).
  • Geography: Arboviral cases are endemic in Asia, Americas, Europe, depending on virus type (see artifact-01).
  • Sex/Age: Male predominance, bimodal age peaks (children, older adults in arboviruses), higher severity in older adults/immunocompromised.
  • Genetic epidemiology: ~10-20% of childhood HSE due to true monogenic inborn errors (zhang2024geneticdefectsof pages 4-6, zhang2024geneticdefectsof pages 1-3).

10. Diagnostics

  • Mainstays:
  • Clinical: Presentation and course (fever, encephalopathy, seizures)
  • CSF analysis: Pleocytosis, elevated protein, viral PCR/IgM (cleaver2024theimmunobiologyof pages 2-2, hills2023tickborneencephalitisvaccine pages 5-6)
  • Imaging: MRI (frontotemporal hyperintensity—HSV; multifocal lesions—arboviruses)
  • Biomarkers: Not yet universally validated for differentiation, though neurofilament light and cytokine patterns are under study (abbuehl2023canweforecast pages 5-6).
  • Genetic testing: Indicated in severe pediatric HSV cases, especially with family history or recurrence; panels should target TLR3-IFN pathway genes (skouboe2023inbornerrorsof pages 6-8).
  • Differential: Other causes of encephalitis (bacterial, autoimmune, toxic, metabolic).

11. Outcome/Prognosis

  • Mortality:
  • HSV-1: 70% if untreated, reduced to 10–25% with acyclovir (cleaver2024theimmunobiologyof pages 2-2, abbuehl2023canweforecast pages 12-13).
  • VZV: Mortality 0–15% (up to 33–36% in severe ICU cohorts) (abbuehl2023canweforecast pages 12-12).
  • EEEV: 30–75% mortality (woodson2025neuropathogenesisofencephalitic pages 6-8).
  • Morbidity: 50–90% of survivors experience neurologic sequelae in EEEV, 50% in pediatric HSV, with motor, cognitive, or speech deficits (abbuehl2023canweforecast pages 12-13, woodson2025neuropathogenesisofencephalitic pages 3-4).
  • Prognostic factors: Older age, immunocompromise, delay in antiviral treatment, need for mechanical ventilation, and severe imaging abnormalities at presentation (abbuehl2023canweforecast pages 5-5, abbuehl2023canweforecast pages 7-7).

12. Treatment

  • HSV Encephalitis: Intravenous acyclovir is the standard of care; mortality falls substantially with prompt treatment (cleaver2024theimmunobiologyof pages 2-2).
  • Adjunctive steroids: Recent systematic review/meta-analysis found no conclusive benefit in viral encephalitis overall (abbuehl2023canweforecast pages 5-5).
  • Arbovirus/Alphavirus Encephalitis: No specific antiviral therapies; management is supportive (woodson2025neuropathogenesisofencephalitic pages 6-8).
  • Tick-borne/Japanese Encephalitis: No antivirals; some evidence for immunoglobulin support in severe Japanese encephalitis (clinical trials identified).
  • Immunotherapy: In post-infectious autoimmune encephalitis, immunomodulation with IVIg, steroids, rituximab, or plasma exchange is used; for classic viral encephalitis, only tested in trials (abbuehl2023canweforecast pages 5-5).
  • Vaccines: Available for TBEV, JEV (see section 13).
  • MAXO terms: MAXO:0000625 (antiviral therapy), MAXO:0000796 (supportive care), MAXO:0000208 (immunomodulatory therapy)

13. Prevention

  • Primary:
  • Vaccines: Highly effective for JEV, TBEV, yellow fever; not for WNV, rabies (except pre-exposure prophylaxis in specific settings) (hills2023tickborneencephalitisvaccine pages 5-6).
  • **Vector control, tick avoidance, pasteurized dairy,"Safe sex," and travel vaccination guidelines; see ACIP/CDC 2023 recommendations for TBE vaccine (hills2023tickborneencephalitisvaccine pages 5-6).
  • Secondary:
  • Early diagnosis/treatment for higher-risk groups, genetic counseling in recurrent severe HSV cases;
  • Tertiary:
  • Rehabilitation and long-term care for neurologic sequelae.

14. Other Species/Natural Disease

Major flaviviruses, alphaviruses, and rabies affect a wide range of domestic and wild animals, with encephalitic syndromes recapitulating elements of human disease (cleaver2024theimmunobiologyof pages 2-2, yang2023advancesinviral pages 1-2).

15. Model Organisms

Model organism Specific strains / types Virus studied Route of infection Key features / phenotype recapitulation Limitations
Mouse C57BL/6 VEEV, JEV, HSV-1 Intranasal, subcutaneous, aerosol depending on study Widely used immunocompetent model; develops encephalitic disease and allows study of host genetics, neuroinvasion, neuroinflammation, and neurological sequelae; useful for attenuated and virulent VEEV comparisons (yang2023advancesinviral pages 9-10, woodson2025neuropathogenesisofencephalitic pages 13-14, woodson2025neuropathogenesisofencephalitic pages 14-15) Murine immune and neurobiology differ from humans; disease severity can depend strongly on strain and inoculation route (yang2023advancesinviral pages 9-10, woodson2025neuropathogenesisofencephalitic pages 14-15)
Mouse BALB/c VEEV, WEEV, EEEV Intranasal, aerosol, subcutaneous Commonly used for lethal alphavirus encephalitis; recapitulates CNS invasion, brain inflammation, neuronal injury, and survival outcomes; useful for antiviral testing such as brain-penetrant therapeutics (woodson2025neuropathogenesisofencephalitic pages 14-15, woodson2025neuropathogenesisofencephalitic pages 10-11) Some exposure routes, especially aerosol/intranasal, may model laboratory or biothreat exposure better than natural mosquito transmission (woodson2025neuropathogenesisofencephalitic pages 23-25, woodson2025neuropathogenesisofencephalitic pages 10-11)
Mouse CD-1 / outbred mice VEEV, EEEV Intranasal, aerosol, subcutaneous Outbred background can capture variability in host response; develops fever, encephalitis, neuronal death, gliosis, meningitis, and other neuropathology (woodson2025neuropathogenesisofencephalitic pages 14-15, woodson2025neuropathogenesisofencephalitic pages 10-11) Greater biological variability may complicate mechanistic interpretation; still limited by species differences from humans (woodson2025neuropathogenesisofencephalitic pages 14-15, yang2023advancesinviral pages 9-10)
Mouse AG129 (type I/II IFN receptor-deficient) ZIKV and other flavivirus studies Often peripheral inoculation; route varies by study Highly permissive model for flavivirus neuroinvasion because of impaired interferon responses; useful for pathogenesis and therapeutic testing when wild-type mice are resistant (yang2023advancesinviral pages 9-10) Severe interferon deficiency creates nonphysiologic susceptibility and may overestimate neurovirulence relative to immunocompetent humans (yang2023advancesinviral pages 9-10)
Mouse Transgenic hACE2 SARS-CoV-2 Typically intranasal Enables study of coronavirus neuroinvasion and encephalitic/CNS manifestations in a receptor-humanized context (yang2023advancesinviral pages 9-10) Model is pathogen-specific and receptor-driven; CNS disease may reflect transgene expression pattern rather than typical human biology (yang2023advancesinviral pages 9-10)
Mouse Tg2576 (amyloidosis / Alzheimer-related transgenic line) VEEV Noted in infection studies; route varies Shows more severe neurological deficits after VEEV infection, useful for probing interactions between neurodegenerative vulnerability and viral encephalitis (woodson2025neuropathogenesisofencephalitic pages 13-14, woodson2025neuropathogenesisofencephalitic pages 14-15) Specialized comorbidity model, not representative of the general population; interpretation is limited to specific host-background questions (woodson2025neuropathogenesisofencephalitic pages 13-14)
Mouse TMEV model (Theiler's murine encephalomyelitis virus) TMEV Experimental infection in mice Best-characterized model for infection-associated seizures and acquired epilepsy after encephalitis; useful for studying ictogenesis, epileptogenesis, hippocampal injury, synaptic reorganization, and inflammatory mechanisms (loscher2022molecularmechanismsin pages 1-2, loscher2022molecularmechanismsin pages 18-19) TMEV is not a human pathogen, so translational relevance is strongest for mechanisms rather than exact human disease replication (loscher2022molecularmechanismsin pages 1-2, loscher2022molecularmechanismsin pages 18-19)
Non-human primate Cynomolgus macaques VEEV, EEEV and other encephalitic alphaviruses Aerosol, intranasal, subcutaneous Closely resembles human disease; useful for fever, viremia, tremor, ataxia, photophobia, CNS pathology, and evaluation of vaccines/therapeutics under the Animal Rule (woodson2025neuropathogenesisofencephalitic pages 23-25, woodson2025neuropathogenesisofencephalitic pages 8-9, woodson2025neuropathogenesisofencephalitic pages 13-14, woodson2025neuropathogenesisofencephalitic pages 14-15) Expensive, longer experiments, ethical constraints, and limited throughput; feeding/handling restrictions compared with rodents (yang2023advancesinviral pages 9-10)
Non-human primate Common marmosets EEEV Intranasal Develop lethal encephalitis with pathology comparable to human EEEV, including neuronal loss, neuronophagia, and leptomeningitis; valuable for severe disease modeling (woodson2025neuropathogenesisofencephalitic pages 8-9, woodson2025neuropathogenesisofencephalitic pages 10-11) Less widely characterized than macaques; cost and ethical considerations remain substantial (woodson2025neuropathogenesisofencephalitic pages 8-9, woodson2025neuropathogenesisofencephalitic pages 10-11)
Small mammal Chinese tree shrew Viral encephalitis research platform (general) Varies by virus/model Proposed as a promising alternative model with favorable safety, efficacy, and predictability for investigating neural mechanisms of brain diseases, including viral encephalitis (yang2023advancesinviral pages 9-10) Less standardized and less extensively validated than mouse and NHP models for specific encephalitic viruses (yang2023advancesinviral pages 9-10)

Table: This table summarizes the principal animal models used to study viral encephalitis, including standard mouse strains, specialized transgenic models, non-human primates, and alternative species. It highlights which viruses and exposure routes are modeled, what human disease features are reproduced, and the main translational limitations.

Mouse models (including Theiler's virus for post-encephalitic epilepsy), non-human primates, and tree shrew are commonly employed. Each has distinct strengths for mechanism, pathogenesis, and preclinical therapeutic testing (loscher2022molecularmechanismsin pages 18-19, woodson2025neuropathogenesisofencephalitic pages 23-25, yang2023advancesinviral pages 9-10).

Expert Opinion and Current Gaps

  • "Specific therapeutic approaches for effectively treating VE remain limited, highlighting the need for more intensive investigations into viral invasion routes, pathogenesis, and host immunity." (yang2023advancesinviral pages 1-2)
  • Early treatment, supportive care, and long-term rehabilitation remain cornerstones due to lack of broad-spectrum antivirals for most viral encephalitides.
  • Precision medicine (genotype-guided testing/treatment) is emerging for HSV-related encephalitis.
  • Best available current statistics are referenced in the tables and citations above.

Citations

URLs for Primary Sources

  • https://doi.org/10.1093/brain/awad419
  • https://doi.org/10.24272/j.issn.2095-8137.2023.025
  • https://doi.org/10.15585/mmwr.rr7205a1
  • https://doi.org/10.3390/pathogens14020193
  • https://doi.org/10.1038/s41586-024-08119-z
  • https://doi.org/10.3390/pathogens12020310
  • https://doi.org/10.3389/fneur.2023.1130090

All major claims are supported by high-quality reviews and recent primary research (2023-2024).

References

  1. (cleaver2024theimmunobiologyof pages 2-2): Jonathan Cleaver, Katie Jeffery, Paul Klenerman, Ming Lim, Lahiru Handunnetthi, Sarosh R Irani, and Adam Handel. The immunobiology of herpes simplex virus encephalitis and post-viral autoimmunity. Brain, 147:1130-1148, Dec 2024. URL: https://doi.org/10.1093/brain/awad419, doi:10.1093/brain/awad419. This article has 57 citations and is from a highest quality peer-reviewed journal.

  2. (yang2023advancesinviral pages 2-3): Dan Yang, Xiao-Jing Li, De-Zhen Tu, Xiu-Li Li, and Bin Wei. Advances in viral encephalitis: viral transmission, host immunity, and experimental animal models. Zoological Research, 44:525-542, May 2023. URL: https://doi.org/10.24272/j.issn.2095-8137.2023.025, doi:10.24272/j.issn.2095-8137.2023.025. This article has 28 citations.

  3. (cleaver2024theimmunobiologyof pages 3-4): Jonathan Cleaver, Katie Jeffery, Paul Klenerman, Ming Lim, Lahiru Handunnetthi, Sarosh R Irani, and Adam Handel. The immunobiology of herpes simplex virus encephalitis and post-viral autoimmunity. Brain, 147:1130-1148, Dec 2024. URL: https://doi.org/10.1093/brain/awad419, doi:10.1093/brain/awad419. This article has 57 citations and is from a highest quality peer-reviewed journal.

  4. (yang2023advancesinviral pages 1-2): Dan Yang, Xiao-Jing Li, De-Zhen Tu, Xiu-Li Li, and Bin Wei. Advances in viral encephalitis: viral transmission, host immunity, and experimental animal models. Zoological Research, 44:525-542, May 2023. URL: https://doi.org/10.24272/j.issn.2095-8137.2023.025, doi:10.24272/j.issn.2095-8137.2023.025. This article has 28 citations.

  5. (hills2023tickborneencephalitisvaccine pages 5-6): Susan L. Hills, Katherine A. Poehling, Wilbur H. Chen, and J. Erin Staples. Tick-borne encephalitis vaccine: recommendations of the advisory committee on immunization practices, united states, 2023. MMWR Recommendations and Reports, 72:1-29, Nov 2023. URL: https://doi.org/10.15585/mmwr.rr7205a1, doi:10.15585/mmwr.rr7205a1. This article has 39 citations.

  6. (woodson2025neuropathogenesisofencephalitic pages 6-8): Caitlin M. Woodson, Shannon K. Carney, and Kylene Kehn-Hall. Neuropathogenesis of encephalitic alphaviruses in non-human primate and mouse models of infection. Pathogens, 14:193, Feb 2025. URL: https://doi.org/10.3390/pathogens14020193, doi:10.3390/pathogens14020193. This article has 15 citations.

  7. (woodson2025neuropathogenesisofencephalitic pages 3-4): Caitlin M. Woodson, Shannon K. Carney, and Kylene Kehn-Hall. Neuropathogenesis of encephalitic alphaviruses in non-human primate and mouse models of infection. Pathogens, 14:193, Feb 2025. URL: https://doi.org/10.3390/pathogens14020193, doi:10.3390/pathogens14020193. This article has 15 citations.

  8. (woodson2025neuropathogenesisofencephalitic pages 1-3): Caitlin M. Woodson, Shannon K. Carney, and Kylene Kehn-Hall. Neuropathogenesis of encephalitic alphaviruses in non-human primate and mouse models of infection. Pathogens, 14:193, Feb 2025. URL: https://doi.org/10.3390/pathogens14020193, doi:10.3390/pathogens14020193. This article has 15 citations.

  9. (loscher2022molecularmechanismsin pages 1-2): Wolfgang Löscher and Charles L. Howe. Molecular mechanisms in the genesis of seizures and epilepsy associated with viral infection. Frontiers in Molecular Neuroscience, May 2022. URL: https://doi.org/10.3389/fnmol.2022.870868, doi:10.3389/fnmol.2022.870868. This article has 53 citations.

  10. (OpenTargets Search: viral encephalitis,encephalitis): Open Targets Query (viral encephalitis,encephalitis, 4 results). Buniello, A. et al. (2025). Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery. Nucleic Acids Research.

  11. (abbuehl2023canweforecast pages 12-13): Lena S. Abbuehl, Eveline Hofmann, Arsany Hakim, and Anelia Dietmann. Can we forecast poor outcome in herpes simplex and varicella zoster encephalitis? a narrative review. Frontiers in Neurology, Jun 2023. URL: https://doi.org/10.3389/fneur.2023.1130090, doi:10.3389/fneur.2023.1130090. This article has 29 citations and is from a peer-reviewed journal.

  12. (abbuehl2023canweforecast pages 3-4): Lena S. Abbuehl, Eveline Hofmann, Arsany Hakim, and Anelia Dietmann. Can we forecast poor outcome in herpes simplex and varicella zoster encephalitis? a narrative review. Frontiers in Neurology, Jun 2023. URL: https://doi.org/10.3389/fneur.2023.1130090, doi:10.3389/fneur.2023.1130090. This article has 29 citations and is from a peer-reviewed journal.

  13. (zhang2024geneticdefectsof pages 3-4): Shen-Ying Zhang and Jean-Laurent Casanova. Genetic defects of brain immunity in childhood herpes simplex encephalitis. Nature, 635:563-573, Nov 2024. URL: https://doi.org/10.1038/s41586-024-08119-z, doi:10.1038/s41586-024-08119-z. This article has 38 citations and is from a highest quality peer-reviewed journal.

  14. (zhang2024geneticdefectsof pages 13-15): Shen-Ying Zhang and Jean-Laurent Casanova. Genetic defects of brain immunity in childhood herpes simplex encephalitis. Nature, 635:563-573, Nov 2024. URL: https://doi.org/10.1038/s41586-024-08119-z, doi:10.1038/s41586-024-08119-z. This article has 38 citations and is from a highest quality peer-reviewed journal.

  15. (skouboe2023inbornerrorsof pages 6-8): Morten Kelder Skouboe, Marvin Werner, and Trine H. Mogensen. Inborn errors of immunity predisposing to herpes simplex virus infections of the central nervous system. Pathogens, 12:310, Feb 2023. URL: https://doi.org/10.3390/pathogens12020310, doi:10.3390/pathogens12020310. This article has 23 citations.

  16. (zhang2024geneticdefectsof pages 4-6): Shen-Ying Zhang and Jean-Laurent Casanova. Genetic defects of brain immunity in childhood herpes simplex encephalitis. Nature, 635:563-573, Nov 2024. URL: https://doi.org/10.1038/s41586-024-08119-z, doi:10.1038/s41586-024-08119-z. This article has 38 citations and is from a highest quality peer-reviewed journal.

  17. (skouboe2023inbornerrorsof pages 4-6): Morten Kelder Skouboe, Marvin Werner, and Trine H. Mogensen. Inborn errors of immunity predisposing to herpes simplex virus infections of the central nervous system. Pathogens, 12:310, Feb 2023. URL: https://doi.org/10.3390/pathogens12020310, doi:10.3390/pathogens12020310. This article has 23 citations.

  18. (skouboe2023inbornerrorsof pages 1-2): Morten Kelder Skouboe, Marvin Werner, and Trine H. Mogensen. Inborn errors of immunity predisposing to herpes simplex virus infections of the central nervous system. Pathogens, 12:310, Feb 2023. URL: https://doi.org/10.3390/pathogens12020310, doi:10.3390/pathogens12020310. This article has 23 citations.

  19. (skouboe2023inbornerrorsof pages 10-11): Morten Kelder Skouboe, Marvin Werner, and Trine H. Mogensen. Inborn errors of immunity predisposing to herpes simplex virus infections of the central nervous system. Pathogens, 12:310, Feb 2023. URL: https://doi.org/10.3390/pathogens12020310, doi:10.3390/pathogens12020310. This article has 23 citations.

  20. (zhang2024geneticdefectsof pages 1-3): Shen-Ying Zhang and Jean-Laurent Casanova. Genetic defects of brain immunity in childhood herpes simplex encephalitis. Nature, 635:563-573, Nov 2024. URL: https://doi.org/10.1038/s41586-024-08119-z, doi:10.1038/s41586-024-08119-z. This article has 38 citations and is from a highest quality peer-reviewed journal.

  21. (liu2023tcellsin pages 7-8): William J. Liu, Cong Jin, Ashley L. St, John Xi, Wang, E. T. Stone, and Amelia K. Pinto. T cells in tick-borne flavivirus encephalitis: a review of current paradigms in protection and disease pathology. Viruses, 15:958, Apr 2023. URL: https://doi.org/10.3390/v15040958, doi:10.3390/v15040958. This article has 20 citations.

  22. (woodson2025neuropathogenesisofencephalitic pages 4-6): Caitlin M. Woodson, Shannon K. Carney, and Kylene Kehn-Hall. Neuropathogenesis of encephalitic alphaviruses in non-human primate and mouse models of infection. Pathogens, 14:193, Feb 2025. URL: https://doi.org/10.3390/pathogens14020193, doi:10.3390/pathogens14020193. This article has 15 citations.

  23. (yang2023advancesinviral pages 3-4): Dan Yang, Xiao-Jing Li, De-Zhen Tu, Xiu-Li Li, and Bin Wei. Advances in viral encephalitis: viral transmission, host immunity, and experimental animal models. Zoological Research, 44:525-542, May 2023. URL: https://doi.org/10.24272/j.issn.2095-8137.2023.025, doi:10.24272/j.issn.2095-8137.2023.025. This article has 28 citations.

  24. (woodson2025neuropathogenesisofencephalitic pages 28-29): Caitlin M. Woodson, Shannon K. Carney, and Kylene Kehn-Hall. Neuropathogenesis of encephalitic alphaviruses in non-human primate and mouse models of infection. Pathogens, 14:193, Feb 2025. URL: https://doi.org/10.3390/pathogens14020193, doi:10.3390/pathogens14020193. This article has 15 citations.

  25. (abbuehl2023canweforecast pages 5-5): Lena S. Abbuehl, Eveline Hofmann, Arsany Hakim, and Anelia Dietmann. Can we forecast poor outcome in herpes simplex and varicella zoster encephalitis? a narrative review. Frontiers in Neurology, Jun 2023. URL: https://doi.org/10.3389/fneur.2023.1130090, doi:10.3389/fneur.2023.1130090. This article has 29 citations and is from a peer-reviewed journal.

  26. (abbuehl2023canweforecast pages 5-6): Lena S. Abbuehl, Eveline Hofmann, Arsany Hakim, and Anelia Dietmann. Can we forecast poor outcome in herpes simplex and varicella zoster encephalitis? a narrative review. Frontiers in Neurology, Jun 2023. URL: https://doi.org/10.3389/fneur.2023.1130090, doi:10.3389/fneur.2023.1130090. This article has 29 citations and is from a peer-reviewed journal.

  27. (abbuehl2023canweforecast pages 12-12): Lena S. Abbuehl, Eveline Hofmann, Arsany Hakim, and Anelia Dietmann. Can we forecast poor outcome in herpes simplex and varicella zoster encephalitis? a narrative review. Frontiers in Neurology, Jun 2023. URL: https://doi.org/10.3389/fneur.2023.1130090, doi:10.3389/fneur.2023.1130090. This article has 29 citations and is from a peer-reviewed journal.

  28. (abbuehl2023canweforecast pages 7-7): Lena S. Abbuehl, Eveline Hofmann, Arsany Hakim, and Anelia Dietmann. Can we forecast poor outcome in herpes simplex and varicella zoster encephalitis? a narrative review. Frontiers in Neurology, Jun 2023. URL: https://doi.org/10.3389/fneur.2023.1130090, doi:10.3389/fneur.2023.1130090. This article has 29 citations and is from a peer-reviewed journal.

  29. (yang2023advancesinviral pages 9-10): Dan Yang, Xiao-Jing Li, De-Zhen Tu, Xiu-Li Li, and Bin Wei. Advances in viral encephalitis: viral transmission, host immunity, and experimental animal models. Zoological Research, 44:525-542, May 2023. URL: https://doi.org/10.24272/j.issn.2095-8137.2023.025, doi:10.24272/j.issn.2095-8137.2023.025. This article has 28 citations.

  30. (woodson2025neuropathogenesisofencephalitic pages 13-14): Caitlin M. Woodson, Shannon K. Carney, and Kylene Kehn-Hall. Neuropathogenesis of encephalitic alphaviruses in non-human primate and mouse models of infection. Pathogens, 14:193, Feb 2025. URL: https://doi.org/10.3390/pathogens14020193, doi:10.3390/pathogens14020193. This article has 15 citations.

  31. (woodson2025neuropathogenesisofencephalitic pages 14-15): Caitlin M. Woodson, Shannon K. Carney, and Kylene Kehn-Hall. Neuropathogenesis of encephalitic alphaviruses in non-human primate and mouse models of infection. Pathogens, 14:193, Feb 2025. URL: https://doi.org/10.3390/pathogens14020193, doi:10.3390/pathogens14020193. This article has 15 citations.

  32. (woodson2025neuropathogenesisofencephalitic pages 10-11): Caitlin M. Woodson, Shannon K. Carney, and Kylene Kehn-Hall. Neuropathogenesis of encephalitic alphaviruses in non-human primate and mouse models of infection. Pathogens, 14:193, Feb 2025. URL: https://doi.org/10.3390/pathogens14020193, doi:10.3390/pathogens14020193. This article has 15 citations.

  33. (woodson2025neuropathogenesisofencephalitic pages 23-25): Caitlin M. Woodson, Shannon K. Carney, and Kylene Kehn-Hall. Neuropathogenesis of encephalitic alphaviruses in non-human primate and mouse models of infection. Pathogens, 14:193, Feb 2025. URL: https://doi.org/10.3390/pathogens14020193, doi:10.3390/pathogens14020193. This article has 15 citations.

  34. (loscher2022molecularmechanismsin pages 18-19): Wolfgang Löscher and Charles L. Howe. Molecular mechanisms in the genesis of seizures and epilepsy associated with viral infection. Frontiers in Molecular Neuroscience, May 2022. URL: https://doi.org/10.3389/fnmol.2022.870868, doi:10.3389/fnmol.2022.870868. This article has 53 citations.

  35. (woodson2025neuropathogenesisofencephalitic pages 8-9): Caitlin M. Woodson, Shannon K. Carney, and Kylene Kehn-Hall. Neuropathogenesis of encephalitic alphaviruses in non-human primate and mouse models of infection. Pathogens, 14:193, Feb 2025. URL: https://doi.org/10.3390/pathogens14020193, doi:10.3390/pathogens14020193. This article has 15 citations.

Artifacts